Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
1000 participants
OBSERVATIONAL
2012-09-30
2012-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Keloids are mostly observed between the ages of 10 and 30. Although keloid is a common condition and the investigators can make assumptions about those living with keloids, the investigators do not know the actual impact of the illness on the overall performance of patients' and how this disease, day to day, is impacting their lives. The investigators are conducting this study, aimed to investigate the psychosocial impact of keloid on daily life. Information is collected anonymously. You must be 18 years of age or older to take this survey. Parents can respond on behalf of their children who are not 18 years of age yet. The online survey will take 20-30 minutes to complete.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Retrospective Study of Keloid Disorder
NCT02923596
Keloid Tissue Bank
NCT01425437
Radiotherapy for Keloids
NCT04722263
Keloid Scarring: Treatment and Pathophysiology
NCT01295099
Gene Expression and Biomarker Profiling of Keloid Skin
NCT03228693
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Informed consent
3. Age above 18 to answer the survey questions
4. Parents shall respond on behalf of their minor children
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tirgan, Michael H., M.D.
INDIV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael H Tirgan, MD
Role: PRINCIPAL_INVESTIGATOR
Keloid Research Foundation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Michael H. Tirgan MD
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11-07
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.